Muhammad Haq, MD
Cardiovascular Disease · Jersey City, NJNPI 1750724811
Payments from drug & device makers
Across 160 payments — averaging $193.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$11K
- Medtronic$9K
- Abbott$5K
- Biotronik Inc.$3K
- Philips North America LLC$1K
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$463
- plus $2K from 16 others
What the payments were for
- Consulting fees$1500%
- Grants$20,04065%
- Travel & lodging$4,36114%
- Food & beverage$5,52318%
- Education$9103%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 21 | $10,622 |
| Medtronic | 17 | $8,832 |
| Abbott | 36 | $4,867 |
| Biotronik Inc. | 24 | $3,147 |
| Philips North America LLC | 9 | $1,437 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 22 | $463 |
| Edwards Lifesciences | 2 | $357 |
| Boehringer Ingelheim | 2 | $243 |
| Medical Device Business Services, Inc. | 1 | $183 |
| Biosense Webster, Inc. | 3 | $167 |
| Novartis | 10 | $164 |
| Impulse Dynamics (USA) Inc. | 1 | $135 |
| E.r. Squibb & Sons, L.L.C. | 1 | $134 |
| Baxter Healthcare | 1 | $50 |
| Bridgebio Pharma, Inc. | 2 | $38 |
| Teva Pharmaceuticals USA, Inc. | 2 | $30 |
| Amgen | 1 | $29 |
| Elutia, Inc. | 1 | $20 |
| Bayer | 1 | $18 |
| Neurocrine Biosciences, Inc. | 1 | $18 |
| Cardiva Medical, Inc. | 1 | $16 |
| Neurelis, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- GENERAL BRADY$5,000
- EMBLEM$5,000
- AVEIR$2,316
- Edora$1,815
- Acticor$1,815
- BioMonitor$1,349
- Solia$1,349
- Rivacor$1,349
- (9124) LM Undivided$1,070
- Sentus$466
- Plexa$466
- SAPIEN 3 Ultra RESILIA$357
- GENERAL - THERAPIES$289
- OPTIMIZER$271
- JARDIANCE$243
- Adapta$234
- Ensite Cardiac Mapping System$207
- HeartMate 3 Left Ventricular Dev$183
- Carto 3$183
- TENDRIL$179
How this compares
$30,984 in reported general payments places this provider in the 90th percentile of 1,006 cardiovascular disease providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 46 | $41,534 |
| Metoprolol Succinate | 23 | $280 |
| Atorvastatin Calcium | 20 | $188 |
| Amiodarone Hcl | 19 | $169 |
| Metoprolol Tartrate | 33 | $154 |
| ClopidogrelClopidogrel Bisulfate | 19 | $150 |
| Losartan Potassium | 16 | $105 |
| Furosemide | 23 | $94 |
| Carvedilol | 14 | $77 |
| Spironolactone | 17 | $54 |
| Lisinopril | 12 | $19 |
Paid to pharmacies, not to this prescriber.
Other cardiovascular disease in Jersey City
- Joven DungoJersey City$104K
- Robert KippermanMorristown$5.3M
- Sharan MahalBridgewater$3.5M
- Linda GillamMorristown$2.2M
- Mark GelerntHaddon Heights$2M
- Robert FishbergSpringfield$1.9M
- Dilip ViswanathHaddon Heights$1.8M
- Marc CohenNewark$1M
- Jasjit WaliaElizabeth$859K
- Sajjad SabirCamden$742K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.